These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 20671272)

  • 1. Increased intraocular pressure in mice treated with dexamethasone.
    Whitlock NA; McKnight B; Corcoran KN; Rodriguez LA; Rice DS
    Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6496-503. PubMed ID: 20671272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stanniocalcin-1 Reduced Intraocular Pressure in Two Models of Ocular Hypertension.
    Roddy GW; Chowdhury UR; Monson KJ; Fautsch MP
    Curr Eye Res; 2021 Oct; 46(10):1525-1530. PubMed ID: 33757401
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of adenosine receptors in resveratrol-induced intraocular pressure lowering in rats with steroid-induced ocular hypertension.
    Razali N; Agarwal R; Agarwal P; Kumar S; Tripathy M; Vasudevan S; Crowston JG; Ismail NM
    Clin Exp Ophthalmol; 2015; 43(1):54-66. PubMed ID: 24995479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid-induced ocular hypertension in normal sheep.
    Gerometta R; Podos SM; Danias J; Candia OA
    Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):669-73. PubMed ID: 18824726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Steroid induced ocular hypertension and glaucoma].
    Călugăru D; Călugăru M
    Oftalmologia; 2009; 53(3):15-33. PubMed ID: 19899544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effects of latanoprost, travoprost, and bimatoprost on circadian intraocular pressure in patients with glaucoma or ocular hypertension.
    Orzalesi N; Rossetti L; Bottoli A; Fogagnolo P
    Ophthalmology; 2006 Feb; 113(2):239-46. PubMed ID: 16458092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the myocilin (MYOC) glaucoma gene in monkey and human steroid-induced ocular hypertension.
    Fingert JH; Clark AF; Craig JE; Alward WL; Snibson GR; McLaughlin M; Tuttle L; Mackey DA; Sheffield VC; Stone EM
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):145-52. PubMed ID: 11133859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re: Outcome of raised intraocular pressure in uveitic eyes with and without a corticosteroid-induced hypertensive response.
    Nazm N; Dubey S; Gandhi M; Pegu J
    Am J Ophthalmol; 2010 Mar; 149(3):525-6; author reply 526-7. PubMed ID: 20172078
    [No Abstract]   [Full Text] [Related]  

  • 9. Myocilin gene expression in the trabecular meshwork of rats in a steroid-induced ocular hypertension model.
    Sawaguchi K; Nakamura Y; Nakamura Y; Sakai H; Sawaguchi S
    Ophthalmic Res; 2005; 37(5):235-42. PubMed ID: 16020952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of raised intraocular pressure in uveitic eyes with and without a corticosteroid-induced hypertensive response.
    Sallam A; Sheth HG; Habot-Wilner Z; Lightman S
    Am J Ophthalmol; 2009 Aug; 148(2):207-213.e1. PubMed ID: 19403113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rabbit model of age-dependant ocular hypertensive response to topical corticosteroids.
    Qin Y; Lam S; Yam GH; Choy KW; Liu DT; Chiu TY; Li WY; Lam DS; Pang CP; Fan DS
    Acta Ophthalmol; 2012 Sep; 90(6):559-63. PubMed ID: 21044276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of timolol, latanoprost, and dorzolamide on circadian IOP in glaucoma or ocular hypertension.
    Orzalesi N; Rossetti L; Invernizzi T; Bottoli A; Autelitano A
    Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2566-73. PubMed ID: 10937568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexamethasone-induced ocular hypertension in perfusion-cultured human eyes.
    Clark AF; Wilson K; de Kater AW; Allingham RR; McCartney MD
    Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):478-89. PubMed ID: 7843916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of selective laser trabeculoplasty on intraocular pressure in patients with intravitreal steroid-induced elevated intraocular pressure.
    Rubin B; Taglienti A; Rothman RF; Marcus CH; Serle JB
    J Glaucoma; 2008; 17(4):287-92. PubMed ID: 18552614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraocular hypotensive effect of a topically applied cortisol metabolite: 3 alpha, 5 beta-tetrahydrocortisol.
    Southren AL; l'Hommedieu D; Gordon GG; Weinstein BI
    Invest Ophthalmol Vis Sci; 1987 May; 28(5):901-3. PubMed ID: 3570698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of ocular hypotensive effect and safety of brinzolamide and timolol added to latanoprost.
    Miura K; Ito K; Okawa C; Sugimoto K; Matsunaga K; Uji Y
    J Glaucoma; 2008; 17(3):233-7. PubMed ID: 18414111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated intraocular pressure associated with steroid treatment for infantile spasms.
    Friling R; Weinberger D; Zeharia A; Lusky M; Mimouni M; Gaaton D; Snir M
    Ophthalmology; 2003 Apr; 110(4):831-4. PubMed ID: 12689911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of tetrandrine on lowering intraocular pressure in animal model with ocular hypertension.
    Huang P; Xu Y; Wei R; Li H; Tang Y; Liu J; Zhang SS; Zhang C
    J Glaucoma; 2011 Mar; 20(3):183-8. PubMed ID: 20440217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central corneal thickness and measured IOP response to topical ocular hypotensive medication in the Ocular Hypertension Treatment Study.
    Shimmyo M
    Am J Ophthalmol; 2005 Jun; 139(6):1148; author reply 1148-9. PubMed ID: 15953471
    [No Abstract]   [Full Text] [Related]  

  • 20. Ultrastructural changes associated with dexamethasone-induced ocular hypertension in mice.
    Overby DR; Bertrand J; Tektas OY; Boussommier-Calleja A; Schicht M; Ethier CR; Woodward DF; Stamer WD; Lütjen-Drecoll E
    Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):4922-33. PubMed ID: 25028360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.